lobbying_activities: 1700367

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1700367	f049a889-2022-43a6-9133-bfa1caf6b5b7	Q2	AMERICAN HEALTH CARE ASSOCIATION	2491	AMERICAN HEALTH CARE ASSOCIATION	2015	second_quarter	PHA	S. 621: Safe Prescribing Act of 2013 - continued monitoring of hydrocodone changes. Continued monitoring of Nurse Agent Continued monitoring of drug disposal issues Continued monitoring of action on antipsychotic reduction efforts. H.R. 3392 Medicare Part D patient Safety & Drug Abuse Prevention Act of 2013	Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,Veterans Affairs, Dept of (VA)		960000	0	0	2015-07-16T16:32:10.600000-04:00